| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.081 | 0.6 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |